1. What Is the Point of Care Cardiac Testing Market?
The Point of Care Cardiac Testing Market covers rapid immunoassay-based and biosensor platforms measuring cardiac biomarkers at or near the patient for rapid chest pain evaluation, heart failure assessment, and cardiovascular risk stratification. Emergency physicians, cardiologists, and critical care nurses deploy POC troponin, BNP, NT-proBNP, D-dimer, and myoglobin tests in emergency departments and intensive care settings for time-sensitive acute coronary syndrome and pulmonary embolism evaluation. The market includes high-sensitivity POC troponin platforms, multiplex cardiac panels, and handheld cardiac biosensor analyzers.
2. Point of Care Cardiac Testing Market Size & Forecast
3. Emerging Technologies
- Microfluidic high-sensitivity troponin cartridges matching central laboratory assay sensitivity in POC format enabling same-day result within ten minutes at the bedside.
- Wearable continuous cardiac biomarker monitoring patches measuring troponin and BNP through microneedle-based interstitial fluid sampling.
- Multiplexed acute MI and heart failure panel measuring troponin, BNP, D-dimer, and CK-MB from a single whole-blood sample.
- AI-powered pre-hospital cardiac risk stratification integrating POC biomarker results with ECG and clinical data for optimal destination hospital selection.
Such innovations are driving change across adjacent industries too. Discover more in our Rapid Antigen Tests Market.
4. Key Market Opportunity
Emergency department high-sensitivity POC troponin adoption represents the largest clinical workflow transformation opportunity. Pre-hospital EMS cardiac POC testing is the fastest-growing new application segment. Heart failure outpatient POC monitoring is the largest primary care market expansion opportunity for cardiac POC.
5. Top Companies in the Point of Care Cardiac Testing Market
The following organisations hold leading positions in the Point of Care Cardiac Testing Market. The full report provides revenue share, SWOT analysis, and competitive benchmarking for each player.
- Abbott Laboratories
- Siemens Healthineers
- Roche Diagnostics
- bioMerieux
- QuidelOrtho
- Radiometer
- Becton Dickinson
- Bosch Healthcare
- Bravura Sciences
- Response Biomedical
6. Market Segmentation
The Point of Care Cardiac Testing Market is analysed across 5 segmentation dimensions. Revenue data, growth rates, and competitive intensity by sub-segment are available in the full report.
| Segmentation | Sub-Segments |
|---|---|
| By Biomarker | High-Sensitivity Troponin POCBNP and NT-proBNP POCD-Dimer POCMyoglobin POCMultiplex Cardiac Panel |
| By Setting | Emergency Department POCIntensive Care UnitPre-Hospital EMS TestingChest Pain UnitPrimary Care |
| By Technology | Fluorescence ImmunoassayElectrochemical BiosensorQuantum Dot EnhancedMultiplex Panel Cartridge |
| By End-User | Hospital Emergency DepartmentsICUsEMS Pre-HospitalChest Pain CentersOutpatient Cardiology |
| By Geography | North AmericaEuropeAsia PacificLatin AmericaMiddle East and Africa |
7. Key Market Trends (2026–2034)
Three major forces are shaping the Point of Care Cardiac Testing Market trajectory over the forecast period:
High-sensitivity POC troponin is the most consequential cardiac POC development as rapid high-sensitivity troponin assays enabling zero and one-hour rule-out protocols reduce emergency department length of stay for chest pain patients.Abbott ARCHITECT hs-cTnI and Siemens Atellica IM hs-cTnI adapted for POC settings are enabling ED chest pain pathways previously requiring central laboratory turnaround times. The high-sensitivity troponin POC capability is reshaping chest pain evaluation workflow fundamentally.
Pre-hospital POC cardiac testing is emerging as EMS services increasingly seek cardiac biomarker testing capability in the ambulance to guide triage and hospital destination decisions.POC troponin and BNP testing in the pre-hospital setting enables more informed destination hospital selection for potential STEMI and acute decompensated heart failure patients. Miniaturized cardiac POC devices compatible with ambulance environments are gaining EMS service interest.
Heart failure POC biomarker testing is creating a primary care and outpatient cardiology application beyond emergency department use.POC BNP and NT-proBNP testing in physician offices and outpatient heart failure clinics enables rapid heart failure decompensation detection without central laboratory referral. The outpatient cardiac POC application is extending the market beyond traditional emergency and hospital acute care settings.
For related market intelligence, see the Point Of Care Testing Market.
8. Segmental Analysis
By biomarker, the high-sensitivity troponin POC segment dominated the Point of Care Cardiac Testing Market in 2025, as high-sensitivity troponin enabling rapid rule-out and rule-in protocols for acute myocardial infarction represents the largest and fastest-growing POC cardiac biomarker category sustaining the largest emergency department adoption globally.
By setting, the pre-hospital EMS testing segment is projected to register the highest growth rate through 2034, as EMS services seeking cardiac biomarker-guided triage decisions before hospital arrival are driving systematic pre-hospital POC cardiac testing adoption.
9. Regional Analysis
Regional demand patterns across the Point of Care Cardiac Testing Market reflect differences in regulation, technological maturity, and capital investment.
Largest Market Share
North America dominated the Point of Care Cardiac Testing Market in 2025, accounting for around 47 percent of global revenue. The United States emergency department infrastructure with the world's highest acute chest pain evaluation volume drives the largest POC cardiac testing market. Abbott, Siemens, and Roche generate dominant U.S. POC cardiac revenue through both platform placements and high-volume cartridge consumption. Moreover, U.S. chest pain unit protocol adoption of POC troponin is systematically replacing central laboratory referral.
Highest CAGR Region
Asia Pacific is projected to register the highest CAGR in the Point of Care Cardiac Testing Market through 2034. The region's rapidly expanding emergency medicine infrastructure combined with high cardiovascular disease burden is driving substantial POC cardiac testing adoption. Chinese emergency department POC cardiac testing investment is growing systematically. Japanese and Korean emergency cardiology programs support systematic high-sensitivity troponin POC adoption.
10. Full Report with Exclusive Insights
The complete published market report includes an in-depth analysis of market dynamics, industry trends, competitive landscape, regional outlook, and future growth opportunities. The study provides detailed market sizing and forecasts across key segments and geographies, along with comprehensive insights into drivers, restraints, opportunities, challenges, technological advancements, regulatory landscape, and evolving consumer and industry trends. The report also features company profiles, strategic developments, market share analysis, and actionable recommendations to support informed business decision-making. Additionally, the syndicated report package typically includes forecast datasets, charts and figures, research methodology, and analyst support for strategic interpretation and planning.
Advanced Strategic & Custom Intelligence
In addition to the standard syndicated report package, TrendX Insights can provide the following advanced strategic analyses and customized intelligence solutions for any market:
Standard Report Coverage
- • Competitor Analysis
- • Country Trade Analysis
- • Import & Export Analysis
- • Porter’s Five Forces Analysis
- • SWOT Analysis by Companies
- • TrendX Insights Quadrant Positioning
- • Pricing Analysis
- • Detailed Macro-Economic Indicators Assessment
- • List of Raw Material Suppliers
- • Regulatory Framework Assessment
- • Supply Chain Resilience Mapping
- • Value Chain Analysis
- • Technology adoption trends and innovation tracking
- • Custom company profiling and benchmarking
Exclusive Sections With Additional Cost
- • Agentic AI Readiness Score
- • TAM, SAM, and SOM Analysis
- • AI Act & Privacy Compliance Audit
- • Channel Partner Ecosystem Mapping
- • China + 1 Strategy Analysis
- • Circular Economy Opportunities Assessment
- • Competitor Benchmarking KPI Analysis
- • Country Trade Analysis
- • Country-level opportunity mapping
- • Digital Maturity Matrix
- • Ecosystem Interdependency Mapping
- • ESG & Decarbonization Roadmap
- • Geopolitical Friction Scorecard
- • Geopolitical Risk Assessment
- • Humanoid Workforce Impact Analysis
- • Investment Heatmap
- • List of Distributors and Channel Partners
- • List of Raw Material Suppliers
- • Market Entry Strategy Assessment
- • Mergers & Acquisitions (M&A) Analysis
- • Patent & Intellectual Property (IP) Analysis
- • Pilot Project Analysis
- • Potential High-Growth Region/Country Investment Assessment
- • Product Comparison Analysis
- • Product Revenue Analysis
- • R&D Investment Analysis in Emerging Technologies
- • Raw Material Scarcity Forecast
Note: For highly customized requirements, deeper strategic assessments, company-specific intelligence, or tailored consulting support, please contact TrendX Insights.
Full Report with Exclusive Insights
Available to clients on request
Explore Our Published Reports Library
This page covers market-level data estimates. For comprehensive published research reports including full methodology, primary data, and detailed company profiles, browse the TrendX Insights Published Reports Library.
Visit Published Reports Library ›11. Related Market Reports
Frequently Asked Questions
The Point of Care Cardiac Testing Market was valued at USD 4.85 Bn in 2025 and is projected to reach USD 12.60 Bn by 2034, growing at a CAGR of 11.2% over the 2026–2034 forecast period.
The Point of Care Cardiac Testing Market is projected to grow at a CAGR of 11.2% from 2026 to 2034.
North America dominated the Point of Care Cardiac Testing Market in 2025, accounting for around 47 percent of global revenue.
The leading companies in the Point of Care Cardiac Testing Market include Abbott Laboratories, Siemens Healthineers, Roche Diagnostics, bioMerieux, QuidelOrtho, Radiometer, Becton Dickinson, Bosch Healthcare, Bravura Sciences, Response Biomedical.
High-sensitivity poc troponin is the most consequential cardiac poc development as rapid high-sensitivity troponin assays enabling zero and one-hour rule-out protocols reduce emergency department length of stay for chest pain patients.
By biomarker, the high-sensitivity troponin POC segment dominated the Point of Care Cardiac Testing Market in 2025, as high-sensitivity troponin enabling rapid rule-out and rule-in protocols for acute myocardial infarction represents the largest and fastest-growing POC cardiac biomarker category sustaining the largest emergency department adoption globally.
How to Order
Purchasing a TrendX Insights report is straightforward. Our process is designed to be transparent and risk-free for buyers, with a 20% upfront model and full delivery before the balance payment.
This is the price of the syndicated report. Any custom inclusions beyond the Table of Contents will be scoped and priced separately. For the full list of what is covered in the syndicated report, refer to the Table of Contents tab.
A curated, condensed version of this report for students, researchers, and academic institutions. Ideal for thesis work, dissertations, and academic projects. Delivered as PDF to your institutional email.
Valid student ID or institutional email required. For educational and non-commercial use only.